Clinical Trials Browser

Androgen-independent Prostate Cancer × Cetuximab × Genitourinary × Clear all

NCT00661492 2016-12-09

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Phase 2 Completed

115 enrolled 16 charts

Androgen-independent Prostate Cancer